| | The second day of a new year may not be as exciting as the first, but it still offers great promise for the 364 days ahead. First Opinion authors kicked off 2022 with an essay on the No surprises Act, which went into effect on Jan. 1, and ended 2021 with essays on blitzscaling in mental health tech, the toll taken by deaths of despair, and more. You can read them all here. Onward to a new year! | | By Stacy Bratcher Don Petersen/AP Beyond prohibiting surprise medical bills, the No Surprises Act also says patients must be given good-faith estimates before receiving care. Read More | By Tarun Galagali and Leonard Schlesinger Adobe Being attentive to blind spots in mental health tech, or not blitzscaling, can help entrepreneurs or investors be successful in this sphere. Read More | By David Introcaso ADOBE Given the well-documented correlation between income and health, HHS's lack of response to deaths of despair is beyond understanding. Read More | Sponsor content by STAT+ Biopharma breakthroughs, business, and policy analysis — at your fingertips Enjoy daily, market-moving analysis of the biotech, pharma, and life sciences industries with STAT Plus. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond. Don't be the last to know. Subscribe today to start reading. | By Christopher Hartnick Adobe A doctor's story became a parable that helped answer a mother's Bible-based assertion that her son was cursed, not infected with a virus. Read More | By Laurent Levy Alex Hogan/STAT, ADOBE The process exists to help more great innovations reach their potential. Now it's time to build the system to support it. Read More | By Daniel Fass FRED TANNEAU/AFP via Getty Images The Nuclear Regulatory Commission's reluctance to change a reporting rule on extravasation is at odds with science and patient safety. Read More | |
No comments